Concepedia
Statistics
Publications
153
Citations
13.1K
H-Index
52
Active since
1929
Affiliations
Christchurch Hospital(Current)
The University of Sydney
Canterbury Health Laboratories
National Health and Medical Research Council
Baylor University
Russell Scott is an author at Christchurch Hospital specializing in medicine, endocrinology, and diabetes mellitus.
Publications per year
1929–2025
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text
Medicine, Endocrinology, Pharmacology +14
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal, Evan A. Stein, Robert Dufour et al. · The Lancet · 2014 · 751 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text
Medicine, Endocrinology, Nephrology +15
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
Russell Scott, Richard O’Brien, Greg Fulcher et al. · Diabetes Care · 2008 · 555 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
Timothy M. E. Davis, R. Ting, James D. Best et al. · Diabetologia · 2010 · 365 citations · Full text
Medicine, Nephrology, Pharmacology +15
1–5 of 153